BioNexus Gene Dividends
| BGLC Stock | USD 5.73 0.91 13.70% |
The current year's Dividend Yield is expected to grow to 0.01, whereas Dividends Paid is forecasted to decline to about 46.6 K. BioNexus Gene's past performance could be the main factor of why investors trade BioNexus Gene Lab stock today. Investors should clearly understand every aspect of the BioNexus Gene dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest BioNexus Gene's dividend schedule and payout information. BioNexus Gene Lab dividends can also provide a clue to the current valuation of BioNexus Gene.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 68.1 K | 46.6 K | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | (0.05) | (0.05) | |
| Dividend Paid And Capex Coverage Ratio | (7.57) | (7.95) |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in BioNexus Gene must own a stock before its ex-dividend date to receive its next dividend.
BioNexus Gene Dividends Paid Over Time
Today, most investors in BioNexus Gene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BioNexus Gene's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of BioNexus Gene dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
BioNexus Gene Historical Dividend Yield Growth
A solid dividend growth pattern of BioNexus Gene could indicate future dividend growth is likely, which can signal long-term profitability for BioNexus Gene Lab. When investors calculate the dividend yield growth rate, they can use any interval of time they wish. They may also calculate the dividend yield growth rate using the least-squares method or simply take an annualized figure over a given time period. Dividend Yield is BioNexus Gene Lab dividend as a percentage of BioNexus Gene stock price. BioNexus Gene Lab dividend yield is a measure of BioNexus Gene stock productivity, which can be interpreted as interest rate earned on an BioNexus Gene investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share. Dividend Yield |
| Timeline |
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNexus Gene. If investors know BioNexus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNexus Gene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (1.21) | Revenue Per Share | Quarterly Revenue Growth (0.10) | Return On Assets |
The market value of BioNexus Gene Lab is measured differently than its book value, which is the value of BioNexus that is recorded on the company's balance sheet. Investors also form their own opinion of BioNexus Gene's value that differs from its market value or its book value, called intrinsic value, which is BioNexus Gene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNexus Gene's market value can be influenced by many factors that don't directly affect BioNexus Gene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNexus Gene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNexus Gene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNexus Gene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.